针对癌症治疗中的编程细胞死亡的内质网膜向策略:方法和前景
Li Liang1, Zhu Zhu2, Xiaohe Jiang3
1State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
概括
用纳米颗粒向内质网膜 (ER) 提供了一种新的癌症治疗方法. 纳米医药可以触发癌细胞的编程细胞死亡 (PCD),克服耐药性并提高治疗效率.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 纳米医学是一种纳米医学.
背景情况:
- 细胞内膜网膜 (ER) 在癌症中具有双重作用,维持平衡并促进癌症的进展.
- 癌细胞的高代谢活动导致ER压力,并激活未折叠蛋白质反应 (UPR) 以求生存.
- 长时间的ER压力可以诱导各种编程细胞死亡 (PCD) 途径.
研究的目的:
- 审查ER向纳米粒子用于癌症治疗的进展.
- 探索纳米医学在调节ER功能和诱导癌细胞PCD中的潜力.
- 讨论开发针对ER的交付平台的局限性和机遇.
主要方法:
- 关于针对ER的纳米粒子的最新科学文献的综述.
- 对ER向的纳米粒子设计原则的分析.
- 在癌症中PCD通路的纳米粒子介导激活的评估.
主要成果:
- 纳米粒子 (NP) 可以设计为精确的ER向癌细胞.
- 针对ER的NP显示了调节ER功能以触发PCD的潜力.
- 在NP设计的进步为癌症治疗提供了新的策略.
结论:
- 对ER的治疗向是一种有前途的抗癌策略.
- 纳米医学为精确的ER调制和PCD诱导提供了一个平台.
- 进一步开发针对ER的NP可以提高癌症治疗效率并克服耐药性.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Overview of Cell Death
7.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K
Protein Networks
4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


